Hecun Zou

P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas

Hecun Zou, Chunjie Wen, Zhigang Peng et al. · Oncology Reports · 2017 · 64 citations · Full text

Neuro-oncology, Tumoral Pathology, Oncology +15

lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients

Hecun Zou, Lanxiang Wu, Yonglong Yang et al. · Oncotarget · 2017 · 57 citations · Full text

Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients

Zhigang Peng, Yu Chen, Hui Cao et al. · Aging · 2020 · 32 citations · Full text

Engineering, Tumor Progression, Pathology +21

Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas

Shuang Li, Hecun Zou, Yingying Shao et al. · Oncotarget · 2017 · 30 citations · Full text

SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer

Cuilin Li, Xiaowei Peng, Jing Lv et al. · Biomedicine & Pharmacotherapy · 2019 · 30 citations · Full text